PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026Tomography0 citationsOpen Access

Eye Lens Radiation Exposure During TAVI: Current Evidence and Imaging-Based Strategies for Dose Reduction

View Full Paper
CZChiara ZanonAFAlessandro FioccoVTVincenzo Tarzia

Key Points

  • This review aims to summarize evidence on eye lens radiation exposure during TAVI and explore methods for exposure reduction.
  • Narrative review of observational and prospective studies on eye lens radiation exposure during TAVI.
  • Examination of direct eye-level dose measurements and surrogate eye lens dose estimates.
  • Focus on procedural and occupational determinants affecting radiation exposure.
  • Operator eye lens doses ranged from 30 to 110 µSv per procedure.
  • Higher exposures noted during transapical/transaortal access and for staff near patients.
  • Lead-free drapes and extra shielding reduced eye dose by 25-40%.
  • Use of RADPAD® decreased operator eye-level dose from 24.3 to 14.8 µSv (p = 0.008).
  • Cumulative exposure may reach annual limits after 150-300 procedures, depending on various factors.

Abstract

Background: Transcatheter aortic valve implantation (TAVI) is increasingly performed in fluoroscopy-intensive environments, raising concerns about occupational eye lens dose (equivalent dose to the eye lens, Hp (3)) and the risk of radiation-induced cataract, particularly after the reduction of recommended annual eye lens dose limits to 20 mSv. Purpose: To summarize evidence on eye lens radiation exposure during TAVI, identify procedural and occupational determinants, and review strategies to reduce exposure with a focus on imaging optimization. Methods: We performed a narrative review of observational and prospective studies reporting direct eye-level dose measurements or validated surrogate eye lens dose estimates (head-level, chest-level, or DAP-normalized) during TAVI and related structural heart procedures. This approach was chosen to provide a qualitative synthesis of the available evidence rather than a formal systematic review. Results: Reported operator eye lens doses typically ranged from 30 to 110 µSv per procedure, with higher exposure during transapical/transaortal access and among staff working close to the patient (e.g., anesthesiologists and circulating nurses). Additional shielding and lead-free drapes reduced normalized eye dose by approximately 25–40%, and RADPAD® use reduced operator eye-level dose from 24.3 to 14.8 µSv per procedure (p = 0.008). At these levels, cumulative exposure may approach recommended regulatory limits after approximately 150–300 procedures, depending on role, access route, and shielding practices. Conclusion: In conclusion, Occupational eye lens exposure during TAVI is clinically relevant and strongly influenced by access route, staff positioning, and imaging-system use. Dose reduction should combine routine eye protection and dedicated eye-level dosimetry with imaging optimization (low pulse-rate fluoroscopy, minimized Digital-Subtraction-Angiography (DSA)/cine acquisitions, tight collimation, avoidance of unnecessary magnification, and correct positioning of ceiling-suspended shields and table skirts).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zanon et al. (2026) studied this question.

synapsesocial.com/papers/69aa70e7531e4c4a9ff5b11chttps://doi.org/10.3390/tomography12030036
Ask AI
Helpful
Bookmark
Share
View Full Paper